In-licensing: Pharmaceutical & Immune related disorders & Phase I

Up-to-date access to technology licensing opportunities worldwide.

In-licensing
Browse

Licensing opportunities

Displaying 1..9 of 9 - per page
Order by

Seking to purchase or in-license late stage or currently marketed assets.

Seeking late stage or currently marketed assets. More

Partners/companies looking for a strategic partnership to give them privileged access to hospital markets in Europe.

LFB is seeking partners/companies which are looking for a strategic partnership to give them privileged access to hospital markets in Europe, ideally having a synergistic presence in North America or South East Asia. More

Cancer treatments

Novel, late stage therapeutics are sought for marketing through a Europe wide specialist sales force. More

UK Marketing Partner

Are you a small to medium company seeking a UK presence? More

Late stage products in CNS, immunology, infectious disease and dermatology areas

Astellas Pharma Taiwan wishes to in-license branded ethical drugs for the Taiwanese market More

Acquisition of UK Primary Care ethical brands

Strategic divestments of primary care sales focussed brands More

Seeking in licensing opportunities for Europe with a priority for France, Germany and UK for products ready to market in hospitals or under clinical development

LFB is looking for alliances or in-licensing opportunities as the European arm for products ready to market or under clinical development, addressing severe diseases treated in hospitals. More

Acquisition of UK Hospital established brands

UK partner for strategic divestments More

Semi modern cancer drugs and adjunctive products for cancer

We are looking for semi modern cancer drugs and adjunctive products for cancer More

Displaying 1..9 of 9 - per page
Order by

Your selection

Industry sector: Pharmaceutical del
Therapeutic target: Immune related disorders del
Development phase: Phase I del

Browse By

Industry sector: Generics; Nutrition; OTC/Non-Prescription; Pediatric; Personal Care; Prescription
Therapeutic target: Adoptive immunotherapy; Amyloidosis; Autoimmune disease (non-specific); Chronic fatigue syndrome; Chronic granulomatous disease; Chronic immunosuppression; Gout; Graft versus host disease; HIV/AIDS; Immune disorder (non-specific); Immune thrombocytopenic purpura; Immunomodulation; Immunostimulation; Immunosuppression; Lupus erythematosis; Myalgic encephalomyelitis; Myasthenia gravis; Neoplastic disease; Organ transplant rejection; Rheumatoid arthritis; Servere combined immunodeficency; Sjogren's syndrome; Systemic sclerosis; Transplant rejection; Xenotransplantation

Products:	Partnering Consulting	Partnering Search	Company Profiling	Comparision	Partneringtools	Reports
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Outsourcing
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search	Add your event
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic	Post your article
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Company releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us